Logo image of USAR

USA RARE EARTH INC (USAR) Stock Fundamental Analysis

USA - NASDAQ:USAR - US91733P1075 - Common Stock

32.61 USD
+1.54 (+4.96%)
Last: 10/10/2025, 9:01:30 PM
35.7 USD
+3.09 (+9.48%)
After Hours: 10/10/2025, 9:01:30 PM
Fundamental Rating

2

Taking everything into account, USAR scores 2 out of 10 in our fundamental rating. USAR was compared to 156 industry peers in the Metals & Mining industry. USAR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. USAR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

USAR had negative earnings in the past year.
USAR had a negative operating cash flow in the past year.
USAR Yearly Net Income VS EBIT VS OCF VS FCFUSAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

Looking at the Return On Assets, with a value of -55.28%, USAR is doing worse than 91.67% of the companies in the same industry.
Industry RankSector Rank
ROA -55.28%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USAR Yearly ROA, ROE, ROICUSAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30

1.3 Margins

USAR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
USAR Yearly Profit, Operating, Gross MarginsUSAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, USAR has about the same amount of shares outstanding.
Compared to 1 year ago, USAR has a worse debt to assets ratio.
USAR Yearly Shares OutstandingUSAR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M
USAR Yearly Total Debt VS Total AssetsUSAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

USAR has an Altman-Z score of 6.61. This indicates that USAR is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.61, USAR is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 6.61
ROIC/WACCN/A
WACCN/A
USAR Yearly LT Debt VS Equity VS FCFUSAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

USAR has a Current Ratio of 15.11. This indicates that USAR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 15.11, USAR belongs to the top of the industry, outperforming 94.23% of the companies in the same industry.
A Quick Ratio of 15.11 indicates that USAR has no problem at all paying its short term obligations.
The Quick ratio of USAR (15.11) is better than 94.23% of its industry peers.
Industry RankSector Rank
Current Ratio 15.11
Quick Ratio 15.11
USAR Yearly Current Assets VS Current LiabilitesUSAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

USAR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -373.48%.
EPS 1Y (TTM)-373.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1677.1%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, USAR will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.63% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-139.06%
EPS Next 2Y-33.9%
EPS Next 3Y12.63%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
USAR Yearly Revenue VS EstimatesUSAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 50M 100M 150M
USAR Yearly EPS VS EstimatesUSAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for USAR. In the last year negative earnings were reported.
Also next year USAR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
USAR Price Earnings VS Forward Price EarningsUSAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USAR Per share dataUSAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as USAR's earnings are expected to grow with 12.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.9%
EPS Next 3Y12.63%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for USAR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

USA RARE EARTH INC

NASDAQ:USAR (10/10/2025, 9:01:30 PM)

After market: 35.7 +3.09 (+9.48%)

32.61

+1.54 (+4.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-06 2025-11-06
Inst Owners22.23%
Inst Owner Change0.01%
Ins Owners1.11%
Ins Owner Change0%
Market Cap3.71B
Analysts82
Price Target19.38 (-40.57%)
Short Float %12.56%
Short Ratio1.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.98%
Min EPS beat(2)24.1%
Max EPS beat(2)75.87%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-6646.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.02
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0
BVpS-0.96
TBVpS-0.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -55.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.11
Quick Ratio 15.11
Altman-Z 6.61
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1089.49%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-373.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1677.1%
EPS Next Y-139.06%
EPS Next 2Y-33.9%
EPS Next 3Y12.63%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1561.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-132.74%
EBIT Next 3Y41.14%
EBIT Next 5YN/A
FCF growth 1Y40.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.76%
OCF growth 3YN/A
OCF growth 5YN/A